539561
REMLIFE
Start SIP
Invest Now
Start SIP in REMLIFE
Performance
- Low
- ₹1
- High
- ₹1
- 52 Week Low
- ₹1
- 52 Week High
- ₹4
- Open Price₹1
- Previous Close₹1
- Volume3,598,136
- 50 DMA₹0.99
- 100 DMA₹1.17
- 200 DMA₹1.86
Investment Returns
- Over 1 Month + 1.18%
- Over 3 Month -44.87%
- Over 6 Month -28.33%
- Over 1 Year -77.37%
Smart Investing Starts Here Start SIP with Supha Pharmachem for Steady Growth!
Supha Pharmachem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -34.9
- PEG Ratio
- 0.3
- Market Cap Cr
- 76
- P/B Ratio
- 0.8
- Average True Range
- 0.06
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.07
- RSI
- 48.62
- MFI
- 33.36
Supha Pharmachem Financials
Supha Pharmachem Technicals
EMA & SMA
Current Price
₹0.86
-0.01
(-1.15%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹0.85
- 50 Day
- ₹0.99
- 100 Day
- ₹1.17
- 200 Day
- ₹1.86
Resistance and Support
0.88
- R3 0.95
- R2 0.93
- R1 0.90
- S1 0.85
- S2 0.83
- S3 0.80
Supha Pharmachem Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-09-22 | Rights Issue & Others | To consider 1. Increase in Authorised Capital. to consider 1. Letter of Offer for the proposed Rights Issue of 49,19,04,000 Equity Shares of Re. 1/- each, aggregating to 4919.04 lakhs for shareholders. 2. Other business matters. |
| 2025-08-04 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-04-24 | Others | Re.0.00 to consider 1. Letter of Offer for the proposed Rights Issue of 49,19,04,000 Equity Shares of Re. 1/- each, aggregating to 4919.04 lakhs for shareholders. 2. Other business matters. |
Supha Pharmachem F&O
About Supha Pharmachem
- NSE Symbol
- REMLIFE
- BSE Symbol
- 539561
- ISIN
- INE549S01036
Similar Stocks to Supha Pharmachem
Supha Pharmachem FAQs
Supha Pharmachem share price is ₹0 As on 19 January, 2026 | 19:15
The Market Cap of Supha Pharmachem is ₹75.9 Cr As on 19 January, 2026 | 19:15
The P/E ratio of Supha Pharmachem is -34.9 As on 19 January, 2026 | 19:15
The PB ratio of Supha Pharmachem is 0.8 As on 19 January, 2026 | 19:15
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.